|
VERA Vera Therapeutics, Inc 1831828 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-121,032,000.00 |
| Balance Sheet |
|
Current Assets
|
$615,802,000.00 |
|
Assets
|
$621,739,000.00 |
|
Current Liabilities
|
$45,149,000.00 |
|
Liabilities
|
$122,042,000.00 |
|
Equity
|
$499,697,000.00 |
|
Shares Out
|
71782904.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-106,500,000.00 |
|
Investing Cash Flow
|
$-137,816,000.00 |
| Market Analysis |
Market Cap
|
$2,372,424,977.20 |
|
Price
|
$31.41 |
|
BVPS
|
6.96 |
|
PB
|
4.75 |
|
EPS
|
-1.69 |
|
FCF
|
$-106,523,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-4.66 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-1.69 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-1.20 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VERA documents filed with the SEC.
VERA Filings
Clear
